FDA Adverse Event Injury Summary report: N

SEE H10

MDR report key: 7740685 · Received August 1, 2018

Report

Report Number
2015691-2018-03108
Event Type
Injury
Date Received
August 1, 2018
Date of Event
July 8, 2018
Report Date
July 8, 2018
Manufacturer
EDWARDS LIFESCIENCES
Product Code
DYE
PMA / PMN Number
SEE H10
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 0

CORRECTED DATA: F10, H6. REFERENCE CAPA-20-00141.

Additional Manufacturer Narrative · 1

THIS MODEL IS NOT SOLD OR MARKETED IN THE U.S. HOWEVER, IT IS SIMILAR TO DEVICE: MODEL #2800; BRAND NAME: CARPENTIER-EDWARDS PERIMOUNT RSR PERICARDIAL BIOPROSTHESIS; PMA #P860057/S001. STRUCTURAL VALVE DETERIORATION (SVD) IS THE MOST COMMON REASON FOR BIOPROSTHESIS EXPLANTS/REPLACEMENTS AND ENCOMPASSES MULTIPLE FAILURE MODES, INCLUDING CALCIFICATION, NON-CALCIFIC DEGENERATION, DEHISCENCE, CUSP THICKENING OR FIBROSIS, OR A COMBINATION OF THESE. SUCH FAILURE MODES MAY OCCUR SINGULARLY OR CONCOMITANTLY. THE REPORTED EVENT CANNOT BE CONFIRMED SINCE THE DEVICE REMAINS IMPLANTED AND IS NOT AVAILABLE FOR EVALUATION. HOWEVER, THIS EVENT WAS MOST LIKELY IMPACTED BY THE PROGRESSION OF THE PATIENT¿S UNDERLYING VALVULAR DISEASE PATHOLOGY WITH SVD. THE DEVICE HISTORY RECORD (DHR) WAS NOT REVIEWED AS THE REPORTED EVENT DOES NOT ALLEGE A MALFUNCTION THAT COULD BE RELATED TO A MANUFACTURING DEFICIENCY AND/OR ONE WAS NOT CONFIRMED THROUGH INVESTIGATION. EDWARDS LIFESCIENCES WILL CONTINUE TO MONITOR ALL REPORTED EVENTS. NO FURTHER ACTIONS ARE REQUIRED AT THIS TIME.

Description of Event or Problem · 1

IT WAS REPORTED THAT A PATIENT WITH A 23MM PERICARDIAL AORTIC VALVE, IMPLANTED FOR APPROXIMATELY 12 YEARS, UNDERWENT A VALVE-IN-VALVE PROCEDURE DUE TO VALVE DEGENERATION. THE TAVR PROCEDURE WAS PERFORMED SUCCESSFULLY AND NO PERIVALVULAR LEAKAGE WAS OBSERVED POST-OPERATION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
583160 SEE H10 REPLACEMENT HEART VALVE DYE EDWARDS LIFESCIENCES SEE H10

Patients

Seq Age Sex Outcome Treatment
1 Hospitalization| R